Sheel Biotech Complete Financial Statements
In FYNone, Sheel Biotech (SHEEL) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00, with a net profit margin of 10.8% and ROE of 13.1%. Full financial statements from FY2021 to FY2025 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see SHEEL stock price BSE.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
SHEEL Revenue, Net Profit & EBITDA — Year-on-Year Growth
SHEEL YoY (March 2025 vs Period) — revenue -100.0%, net profit -100.0%, EBITDA -100.0%, expenses -100.0%. Explore SHEEL Benjamin Graham valuation to estimate fundamental worth using multiple valuation models.
SHEEL Income Statement — Revenue, EBITDA & Net Profit
Sheel Biotech revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (None) — net profit margin 10.8%. Review Sheel Biotech price earnings to evaluate earnings-based valuation against sector peers.
| Particulars | None | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 102 | 93 | 80 | 71 | 63 |
| Expenses | 0 | 87 | 78 | 71 | 64 | 57 |
| EBITDA | 0 | 16 | 15 | 9 | 7 | 7 |
| Operating Profit Margin % | 0.00% | 15.00% | 16.00% | 11.00% | 9.00% | 10.00% |
| Depreciation | 0 | 1 | 1 | 1 | 1 | 1 |
| Interest | 0 | 2 | 2 | 2 | 1 | 1 |
| Profit Before Tax | 0 | 13 | 12 | 6 | 5 | 5 |
| Tax | 0 | 2 | 2 | 1 | 0 | 0 |
| Net Profit | 0 | 11 | 11 | 5 | 5 | 5 |
| Earnings Per Share (₹) | 0.00 | 7.21 | 7.22 | 3.50 | 3.11 | 11.58 |
SHEEL Balance Sheet — Assets, Liabilities & Shareholders' Equity
SHEEL total assets ₹113 Cr, total equity ₹84 Cr, total liabilities ₹ Cr (2025) — ROE 13.1%.
| Particulars | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| ASSETS | |||||
| Total Assets | 113 | 106 | 94 | 93 | 82 |
| Current Assets | 101 | 95 | 83 | 83 | 74 |
| Fixed Assets | 8 | 7 | 8 | 8 | 8 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 106 | 99 | 86 | 85 | 75 |
| LIABILITIES | |||||
| Total Liabilities | |||||
| Current Liabilities | 5 | 11 | 10 | 14 | 12 |
| Non-Current Liabilities | |||||
| SHAREHOLDERS' EQUITY | |||||
| Total Equity | 84 | 73 | 64 | 60 | 57 |
| Share Capital | 15 | 4 | 4 | 4 | 4 |
| Reserves & Surplus | 69 | 69 | 59 | 56 | 53 |
SHEEL Cash Flow Statement — Operating, Investing & Financing
Sheel Biotech operating cash flow ₹9 Cr, investing ₹-2 Cr, financing ₹-7 Cr, net cash flow ₹0 Cr (2025).
| Particulars | March 2025 | March 2024 | March 2023 | March 2022 |
|---|---|---|---|---|
| Operating Activities | 9 | -1 | 9 | 2 |
| Investing Activities | -2 | 0 | -2 | -2 |
| Financing Activities | -7 | 2 | -7 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 |